STAT+: Definium LSD therapy helped patients with major depression in late-stage trial

🇺🇸 STAT News Health (US) —
STAT+: Definium LSD therapy helped patients with major depression in late-stage trial

AI Summary

Definium Therapeutics reported that its LSD therapy showed positive results for patients with major depression in the first Phase 3 trial. This success brings the psychedelic drug closer to potential regulatory approval.

Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.

Health AI & Tech Definium Therapeutics LSD therapy major depression Phase 3 trial psychedelic drugs healthcare innovation

Read original source →